ARCHIVES

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | March 23, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy

May 20, 1994

Pilot Projects Scheduled To Begin Next Summer

December 4, 1998

Division Directors Won’t Control Grants Budget, Upton Insists

February 24, 1978